标题
Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
作者
关键词
-
出版物
Nature Reviews Neurology
Volume 14, Issue 4, Pages 225-236
出版商
Springer Nature
发表日期
2018-02-16
DOI
10.1038/nrneurol.2018.9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 18F-Florbetaben PET beta-amyloid binding expressed in Centiloids
- (2017) Christopher C. Rowe et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer’s Disease with Positron Emission Tomography
- (2017) Luca C. Gobbi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Is Tau Imaging More Than Just Upside-Down 18 F-FDG Imaging?
- (2017) Thilo van Eimeren et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Evaluation of 18 F-JNJ64349311, a Novel PET Tracer for Tau Imaging
- (2017) Lieven Declercq et al. JOURNAL OF NUCLEAR MEDICINE
- Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
- (2017) Kok Pin Ng et al. Alzheimers Research & Therapy
- Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease
- (2017) Chenjie Xia et al. JAMA Neurology
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
- (2016) Bruno Dubois et al. Alzheimers & Dementia
- AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies
- (2016) Kejal Kantarci et al. ANNALS OF NEUROLOGY
- [F-18]AV-1451 positron emission tomography retention in choroid plexus: More than “off-target” binding
- (2016) Milos D. Ikonomovic et al. ANNALS OF NEUROLOGY
- Distinct tau PET imaging patterns in typical and atypical Alzheimer’s disease
- (2016) Marie Sarazin et al. BRAIN
- The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging
- (2016) Brian A. Gordon et al. BRAIN
- Effects of transthyretin on thyroxine and β-amyloid removal from cerebrospinal fluid in mice
- (2016) Ruoli Chen et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Tau imaging with [18F]THK-5351 in progressive supranuclear palsy
- (2016) A. Ishiki et al. EUROPEAN JOURNAL OF NEUROLOGY
- Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)
- (2016) Abbas M. Walji et al. JOURNAL OF MEDICINAL CHEMISTRY
- Standardized Expression of 18F-NAV4694 and 11C-PiB -Amyloid PET Results with the Centiloid Scale
- (2016) C. C. Rowe et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study
- (2016) Samantha C Burnham et al. LANCET NEUROLOGY
- Tau imaging in progressive supranuclear palsy
- (2016) Alexandra Perez-Soriano et al. MOVEMENT DISORDERS
- Acceleration of hippocampal atrophy rates in asymptomatic amyloidosis
- (2016) K. Abigail Andrews et al. NEUROBIOLOGY OF AGING
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Tau PET in Alzheimer disease and mild cognitive impairment
- (2016) Hanna Cho et al. NEUROLOGY
- PET Imaging of Tau Deposition in the Aging Human Brain
- (2016) Michael Schöll et al. NEURON
- Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer’s Disease Patients Measured Using [18F] THK-5351
- (2016) Samuel N. Lockhart et al. PLoS One
- Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
- (2016) Matthew R. Brier et al. Science Translational Medicine
- Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy
- (2016) Liang Wang et al. JAMA Neurology
- An autoradiographic evaluation of AV-1451 Tau PET in dementia
- (2016) Val J. Lowe et al. Acta Neuropathologica Communications
- PART, a distinct tauopathy, different from classical sporadic Alzheimer disease
- (2015) Kurt A. Jellinger et al. ACTA NEUROPATHOLOGICA
- PART is part of Alzheimer disease
- (2015) Charles Duyckaerts et al. ACTA NEUROPATHOLOGICA
- The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
- (2015) William E. Klunk et al. Alzheimers & Dementia
- Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
- (2015) Osama Sabri et al. Alzheimers & Dementia
- Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
- (2015) Marta Marquié et al. ANNALS OF NEUROLOGY
- Tau positron emission tomographic imaging in aging and early Alzheimer disease
- (2015) Keith A. Johnson et al. ANNALS OF NEUROLOGY
- The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features
- (2015) Rik Ossenkoppele et al. BRAIN
- Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease
- (2015) Rik Ossenkoppele et al. HUMAN BRAIN MAPPING
- Prevalence of Amyloid PET Positivity in Dementia Syndromes
- (2015) Rik Ossenkoppele et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Measurement of Longitudinal -Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios
- (2015) S. M. Landau et al. JOURNAL OF NUCLEAR MEDICINE
- Tau imaging: early progress and future directions
- (2015) Victor L Villemagne et al. LANCET NEUROLOGY
- Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease
- (2015) Jon B. Toledo et al. JAMA Neurology
- Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density
- (2015) Craig Curtis et al. JAMA Neurology
- High Affinity Radiopharmaceuticals Based Upon Lansoprazole for PET Imaging of Aggregated Tau in Alzheimer’s Disease and Progressive Supranuclear Palsy: Synthesis, Preclinical Evaluation, and Lead Selection
- (2014) Maria V. Fawaz et al. ACS Chemical Neuroscience
- Primary age-related tauopathy (PART): a common pathology associated with human aging
- (2014) John F. Crary et al. ACTA NEUROPATHOLOGICA
- PART and SNAP
- (2014) Clifford R. Jack ACTA NEUROPATHOLOGICA
- Predicting Alzheimer disease with β-amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing
- (2014) Christopher C. Rowe et al. ANNALS OF NEUROLOGY
- Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy
- (2014) Rik Ossenkoppele et al. ANNALS OF NEUROLOGY
- In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease
- (2014) Victor L. Villemagne et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study
- (2014) Kevin T Ong et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study
- (2014) P M Doraiswamy et al. MOLECULAR PSYCHIATRY
- The A4 Study: Stopping AD Before Symptoms Begin?
- (2014) R. A. Sperling et al. Science Translational Medicine
- Synergistic Effect of β-Amyloid and Neurodegeneration on Cognitive Decline in Clinically Normal Individuals
- (2014) Elizabeth C. Mormino et al. JAMA Neurology
- Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
- (2013) Keith A. Johnson et al. Alzheimers & Dementia
- Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid
- (2013) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue
- (2013) R. Ni et al. BRAIN
- Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT
- (2013) Judith E. Kalinyak et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
- (2013) Stephanie JB Vos et al. LANCET NEUROLOGY
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later
- (2013) C. M. Roe et al. NEUROLOGY
- Preclinical AD predicts decline in memory and executive functions in subjective complaints
- (2013) A. C. van Harten et al. NEUROLOGY
- Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
- (2013) A. Prestia et al. NEUROLOGY
- Brain -amyloid load approaches a plateau
- (2013) C. R. Jack et al. NEUROLOGY
- Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
- (2013) Masahiro Maruyama et al. NEURON
- Biomarker Modeling of Alzheimer’s Disease
- (2013) Clifford R. Jack et al. NEURON
- Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials
- (2013) K. Abigail Andrews et al. PLoS One
- 18F-florbetaben Aβ imaging in mild cognitive impairment
- (2013) Kevin Ong et al. Alzheimers Research & Therapy
- Cross-sectional and Longitudinal Analysis of the Relationship Between Aβ Deposition, Cortical Thickness, and Memory in Cognitively Unimpaired Individuals and in Alzheimer Disease
- (2013) Vincent Doré et al. JAMA Neurology
- Amyloid imaging in dementias with atypical presentation
- (2012) David A. Wolk et al. Alzheimers & Dementia
- Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study
- (2012) Nicolas Villain et al. BRAIN
- Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment
- (2012) V. Camus et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
- (2012) Thomas G. Beach et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
- (2012) Reisa Sperling et al. LANCET NEUROLOGY
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
- (2012) Christopher M Clark et al. LANCET NEUROLOGY
- An In Vivo Evaluation of Cerebral Cortical Amyloid with [18F]Flutemetamol Using Positron Emission Tomography Compared with Parietal Biopsy Samples in Living Normal Pressure Hydrocephalus Patients
- (2012) Dean F. Wong et al. MOLECULAR IMAGING AND BIOLOGY
- Toward a multifactorial model of Alzheimer disease
- (2012) Martha Storandt et al. NEUROBIOLOGY OF AGING
- Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals
- (2012) Reisa A. Sperling et al. NEUROBIOLOGY OF AGING
- Combination of Biomarkers: PET [18F]Flutemetamol Imaging and Structural MRI in Dementia and Mild Cognitive Impairment
- (2012) Lennart Thurfjell et al. Neurodegenerative Diseases
- Accelerated cortical atrophy in cognitively normal elderly with high -amyloid deposition
- (2012) G. Chetelat et al. NEUROLOGY
- Amyloid- assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study
- (2012) P. M. Doraiswamy et al. NEUROLOGY
- In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer
- (2012) Michelle T. Fodero-Tavoletti et al. NUCLEAR MEDICINE AND BIOLOGY
- How golden is the gold standard of neuropathology in dementia?
- (2011) Philip Scheltens et al. Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Amyloid-beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B data
- (2011) Andrei G. Vlassenko et al. ANNALS OF NEUROLOGY
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
- (2011) Victor L. Villemagne et al. ANNALS OF NEUROLOGY
- An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
- (2011) Clifford R. Jack et al. ANNALS OF NEUROLOGY
- Positron Emission Tomography and Neuropathologic Estimates of Fibrillar Amyloid-β in a Patient With Down Syndrome and Alzheimer Disease
- (2011) Marwan N. Sabbagh ARCHIVES OF NEUROLOGY
- Association Between In Vivo Fluorine 18–Labeled Flutemetamol Amyloid Positron Emission Tomography Imaging and In Vivo Cerebral Cortical Histopathology
- (2011) David A. Wolk ARCHIVES OF NEUROLOGY
- Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease
- (2011) Adam S. Fleisher ARCHIVES OF NEUROLOGY
- Amyloid-Dependent and Amyloid-Independent Stages of Alzheimer Disease
- (2011) Bradley T. Hyman ARCHIVES OF NEUROLOGY
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- Regional Expansion of Hypometabolism in Alzheimer's Disease Follows Amyloid Deposition with Temporal Delay
- (2011) Stefan Förster et al. BIOLOGICAL PSYCHIATRY
- Spatial patterns of brain amyloid- burden and atrophy rate associations in mild cognitive impairment
- (2011) D. Tosun et al. BRAIN
- Subtypes of progressive aphasia: application of the international consensus criteria and validation using β-amyloid imaging
- (2011) Cristian E. Leyton et al. BRAIN
- Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden
- (2011) Alexander Drzezga et al. BRAIN
- In Vivo Human Amyloid Imaging
- (2011) J. Sojkova et al. Current Alzheimer Research
- Use of Florbetapir-PET for Imaging β-Amyloid Pathology
- (2011) Christopher M. Clark JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- In vivo demonstration of amyloid burden in posterior cortical atrophy: a case series with PET and CSF findings
- (2011) Maïté Formaglio et al. JOURNAL OF NEUROLOGY
- Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias
- (2011) V. L. Villemagne et al. JOURNAL OF NUCLEAR MEDICINE
- Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
- (2011) Henryk Barthel et al. LANCET NEUROLOGY
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview
- (2011) John C. Morris et al. NEUROBIOLOGY OF AGING
- Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD
- (2011) G. D. Rabinovici et al. NEUROLOGY
- Testing the Right Target and Right Drug at the Right Stage
- (2011) R. A. Sperling et al. Science Translational Medicine
- Florbetapir F-18: A Histopathologically Validated Beta-Amyloid Positron Emission Tomography Imaging Agent
- (2011) John Lister-James et al. SEMINARS IN NUCLEAR MEDICINE
- Amyloid imaging in prodromal Alzheimer's disease
- (2011) Rik Ossenkoppele et al. Alzheimers Research & Therapy
- Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy
- (2010) Gregory A. Dierksen et al. ANNALS OF NEUROLOGY
- 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial
- (2010) Rik Vandenberghe et al. ANNALS OF NEUROLOGY
- Amyloid-β associated cortical thinning in clinically normal elderly
- (2010) J. Alex Becker et al. ANNALS OF NEUROLOGY
- Increased metabolic vulnerability in early-onset Alzheimer’s disease is not related to amyloid burden
- (2010) Gil D. Rabinovici et al. BRAIN
- Frontotemporal Lobar Degeneration
- (2010) Gil D. Rabinovici et al. CNS DRUGS
- High PIB Retention in Alzheimers Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters
- (2010) A. Forsberg et al. Current Alzheimer Research
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
- (2010) Christopher C. Rowe et al. NEUROBIOLOGY OF AGING
- Cognition, glucose metabolism and amyloid burden in Alzheimer's disease
- (2010) Ansgar J. Furst et al. NEUROBIOLOGY OF AGING
- Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes
- (2010) M.E. Kalaitzakis et al. NEUROBIOLOGY OF DISEASE
- Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB
- (2010) S. M. Resnick et al. NEUROLOGY
- -Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
- (2010) P. Bourgeat et al. NEUROLOGY
- Pro: Can biomarkers be gold standards in Alzheimer's disease?
- (2010) Reisa Sperling et al. Alzheimers Research & Therapy
- APOEpredicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging
- (2009) John C. Morris et al. ANNALS OF NEUROLOGY
- High Striatal Amyloid β-Peptide Deposition Across Different Autosomal Alzheimer Disease Mutation Types
- (2009) Victor L. Villemagne et al. ARCHIVES OF NEUROLOGY
- A new subtype of frontotemporal lobar degeneration with FUS pathology
- (2009) M. Neumann et al. BRAIN
- Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
- (2009) Clifford R. Jack et al. BRAIN
- Cerebrospinal fluid tau and ptau181increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
- (2009) Anne M. Fagan et al. EMBO Molecular Medicine
- 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease
- (2009) V L Villemagne et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Basal Cerebral Metabolism May Modulate the Cognitive Effects of A in Mild Cognitive Impairment: An Example of Brain Reserve
- (2009) A. D. Cohen et al. JOURNAL OF NEUROSCIENCE
- Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease
- (2009) N. Nelissen et al. JOURNAL OF NUCLEAR MEDICINE
- Relationship of Cerebrospinal Fluid Markers to 11C-PiB and 18F-FDDNP Binding
- (2009) N. Tolboom et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of 18F-FDG and PiB PET in Cognitive Impairment
- (2009) V. J. Lowe et al. JOURNAL OF NUCLEAR MEDICINE
- Challenges in the conduct of disease-modifying trials in ad: Practical experience from a phase 2 trial of TAU-aggregation inhibitor therapy
- (2009) C. Wischik et al. Journal of Nutrition Health & Aging
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study
- (2009) A. Okello et al. NEUROLOGY
- Fibrillar amyloid- burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
- (2009) E. M. Reiman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia
- (2008) Gil D. Rabinovici et al. ANNALS OF NEUROLOGY
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
- (2008) Howard Jay Aizenstein et al. ARCHIVES OF NEUROLOGY
- Magnetic Resonance Imaging White Matter Hyperintensities and Brain Volume in the Prediction of Mild Cognitive Impairment and Dementia
- (2008) Eric E. Smith et al. ARCHIVES OF NEUROLOGY
- Synthesis of 18F-labelled 2-(4′-fluorophenyl)-1,3-benzothiazole and evaluation as amyloid imaging agent in comparison with [11C]PIB
- (2008) K. Serdons et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions
- (2008) Ian R. A. Mackenzie et al. BRAIN
- PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease
- (2008) J. Koivunen et al. BRAIN
- Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
- (2008) E. C. Mormino et al. BRAIN
- 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
- (2008) Clifford R. Jack et al. BRAIN
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
- (2008) Milos D. Ikonomovic et al. BRAIN
- PET Amyloid Ligand [11C]PIB Uptake and Cerebrospinal Fluid β-Amyloid in Mild Cognitive Impairment
- (2008) J. Koivunen et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
- (2008) P Edison et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism
- (2008) Christopher C Rowe et al. LANCET NEUROLOGY
- The ART of Loss: Aβ Imaging in the Evaluation of Alzheimer’s Disease and other Dementias
- (2008) Victor L. Villemagne et al. MOLECULAR NEUROBIOLOGY
- Imaging amyloid deposition in Lewy body diseases
- (2008) S. N. Gomperts et al. NEUROLOGY
- Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease
- (2008) V.L. Villemagne et al. NEUROPSYCHOLOGIA
- PET imaging of amyloid deposition in patients with mild cognitive impairment
- (2007) Anton Forsberg et al. NEUROBIOLOGY OF AGING
- Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer’s disease
- (2007) Alexander Drzezga et al. NEUROIMAGE
- [11C]-PIB imaging in patients with Parkinson's disease: Preliminary results
- (2007) A. Johansson et al. PARKINSONISM & RELATED DISORDERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started